298 related articles for article (PubMed ID: 18347313)
1. SOX1 autoantibodies: tumor markers in LEMS patients?
Lang B; Evoli A
Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313
[No Abstract] [Full Text] [Related]
2. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
3. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma.
Lipka AF; Verschuuren JJ; Titulaer MJ
Ann N Y Acad Sci; 2012 Dec; 1275():70-7. PubMed ID: 23278580
[TBL] [Abstract][Full Text] [Related]
4. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
5. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
[TBL] [Abstract][Full Text] [Related]
6. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
[TBL] [Abstract][Full Text] [Related]
7. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
Vural B; Chen LC; Saip P; Chen YT; Ustuner Z; Gonen M; Simpson AJ; Old LJ; Ozbek U; Gure AO
Cancer; 2005 Jun; 103(12):2575-83. PubMed ID: 15880380
[TBL] [Abstract][Full Text] [Related]
8. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.
Maddison P; Newsom-Davis J; Mills KR; Souhami RL
Lancet; 1999 Jan; 353(9147):117-8. PubMed ID: 10023900
[No Abstract] [Full Text] [Related]
9. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
Titulaer MJ; Lang B; Verschuuren JJ
Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
[TBL] [Abstract][Full Text] [Related]
10. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome.
Takamori M; Takahashi M; Yasukawa Y; Iwasa K; Nemoto Y; Suenaga A; Nagataki S; Nakamura T
J Neurol Sci; 1995 Nov; 133(1-2):95-101. PubMed ID: 8583238
[TBL] [Abstract][Full Text] [Related]
12. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
13. [Lambert-Eaton myasthenia syndrome--review with case report].
Engler F
Fortschr Neurol Psychiatr; 1990 Dec; 58(12):447-54. PubMed ID: 1964928
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer.
Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E
Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255
[TBL] [Abstract][Full Text] [Related]
15. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
Nakao Y; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Ito M; Kono S; Eguchi K
Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):685-90. PubMed ID: 9627478
[No Abstract] [Full Text] [Related]
16. Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.
Martin-Moutot N; De Haro L; Seagar M
J Neuroimmunol; 2008 Jun; 197(1):47-53. PubMed ID: 18474401
[TBL] [Abstract][Full Text] [Related]
17. Phoneutria nigriventer omega-Phonetoxin IIA: a new tool for anti-calcium channel autoantibody assays in Lambert-Eaton myasthenic syndrome.
Martin-Moutot N; Haro Ld; Santos RG; Mori Y; Seagar M
Neurobiol Dis; 2006 Apr; 22(1):57-63. PubMed ID: 16289869
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
Rozsa C; Vincent A; Aranyi Z; Kovacs GG; Komoly S; Illes Z
Ideggyogy Sz; 2008 Sep; 61(9-10):325-8. PubMed ID: 18841652
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel autoantibody and non-small-cell lung cancer in patients with Lambert-Eaton syndrome.
Sher E; Comola M; Nemni R; Canal N; Clementi F
Lancet; 1990 Feb; 335(8686):413. PubMed ID: 1968140
[No Abstract] [Full Text] [Related]
20. Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome.
Hermitte L; Martin-Moutot N; Boucraut J; Barone R; Atlan-Gepner C; Seagar M; Pouget J; Kleisbauer JP; Couraud F; Vialettes B
J Clin Immunol; 2000 Jul; 20(4):287-93. PubMed ID: 10939716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
